176 related articles for article (PubMed ID: 38228467)
1. Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.
Jones LK; Romagnoli KM; Schubert TJ; Clegg K; Kirchner HL; Hu Y; Cawley D; Norelli V; Williams MS; Gidding SS; Rahm AK
J Clin Lipidol; 2024; 18(2):e176-e188. PubMed ID: 38228467
[TBL] [Abstract][Full Text] [Related]
2. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
[TBL] [Abstract][Full Text] [Related]
3. Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.
Jones LK; Calvo EM; Campbell-Salome G; Walters NL; Brangan A; Rodriguez G; Ahmed CD; Morgan KM; Gidding SS; Williams MS; Brownson RC; Seaton TL; Goldberg AC; McGowan MP; Rahm AK; Sturm AC
Front Health Serv; 2023; 3():1104311. PubMed ID: 37188259
[TBL] [Abstract][Full Text] [Related]
4. Parental Attitudes and Ideas Regarding Newborn Screening for Familial Hypercholesterolemia.
Tobik K; Orland KM; Zhang X; Garcia K; Peterson AL
Matern Child Health J; 2023 Jun; 27(6):978-983. PubMed ID: 36964843
[TBL] [Abstract][Full Text] [Related]
5. Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.
Jones LK; Gidding SS; Seaton TL; Goldberg A; Gregor C; Sturm AC; Brownson RC; Rahm AK; Williams MS
Res Social Adm Pharm; 2020 Mar; 16(3):390-395. PubMed ID: 31229402
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.
Birkenhead K; Sullivan D; Trumble C; Spinks C; Srinivasan S; Partington A; Elias L; Hespe CM; Fleming G; Li S; Calder M; Robertson E; Trent R; Sarkies MN
BMJ Open; 2024 May; 14(5):e082699. PubMed ID: 38692720
[TBL] [Abstract][Full Text] [Related]
8. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
[TBL] [Abstract][Full Text] [Related]
9. Applying implementation science to improve care for familial hypercholesterolemia.
Jones LK; Brownson RC; Williams MS
Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):141-151. PubMed ID: 34839326
[TBL] [Abstract][Full Text] [Related]
10. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
11. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia.
Sarkies MN; Testa L; Best S; Moullin JC; Sullivan D; Bishop W; Kostner K; Clifton P; Hare D; Brett T; Hutchinson K; Black A; Braithwaite J; Nicholls SJ; Kangaharan N; Pang J; Abhayaratna W; Horton A; Watts GF
Heart Lung Circ; 2023 Nov; 32(11):1347-1353. PubMed ID: 37865587
[TBL] [Abstract][Full Text] [Related]
12. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.
Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC
Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803
[TBL] [Abstract][Full Text] [Related]
13. Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA.
Miller DM; Gaviglio A; Zierhut HA
Public Health Genomics; 2021; 24(3-4):110-122. PubMed ID: 33853081
[TBL] [Abstract][Full Text] [Related]
14. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
Brett T; Qureshi N; Gidding S; Watts GF
Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
[TBL] [Abstract][Full Text] [Related]
15. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
[TBL] [Abstract][Full Text] [Related]
16. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.
Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Mata P
Vasc Health Risk Manag; 2020; 16():11-25. PubMed ID: 32021224
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
Bucholz EM; Rodday AM; Kolor K; Khoury MJ; de Ferranti SD
Circulation; 2018 May; 137(21):2218-2230. PubMed ID: 29581125
[TBL] [Abstract][Full Text] [Related]
18. Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.
Jones LK; Sturm AC; Seaton TL; Gregor C; Gidding SS; Williams MS; Rahm AK
PLoS One; 2020; 15(12):e0244193. PubMed ID: 33362269
[TBL] [Abstract][Full Text] [Related]
19. Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment.
Hardcastle SJ; Legge E; Laundy CS; Egan SJ; French R; Watts GF; Hagger MS
Int J Behav Med; 2015 Feb; 22(1):92-100. PubMed ID: 24585182
[TBL] [Abstract][Full Text] [Related]
20. Detecting familial hypercholesterolemia earlier in life by actively searching for affected children:The DECOPIN project.
Ibarretxe D; Rodríguez-Borjabad C; Feliu A; Bilbao JÁ; Masana L; Plana N
Atherosclerosis; 2018 Nov; 278():210-216. PubMed ID: 30312929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
